Evidence map›Paper›PMID 32435839›Full record

ArticleHerz2021

Left ventricular systolic dysfunction in patients with unprotected left main coronary artery disease.

Yu Pan, Qi Qiu, Wei-Hong Ren, Xian-Peng Yu, Ze-Sen Liu, Jian-Zeng Dong

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Herz, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yu PanDepartment of Cardiology, Beijing AnZhen Hospital, Capital Medical University, Beijing, China.
Qi QiuDepartment of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wei-Hong RenDepartment of Pathology, Aviation General Hospital of China Medical University, China Medical University, Beijing, China.
Xian-Peng YuDepartment of Cardiology, Beijing AnZhen Hospital, Capital Medical University, Beijing, China.
Ze-Sen LiuDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Jian-Zeng DongDepartment of Cardiology, Beijing AnZhen Hospital, Capital Medical University, Beijing, China. jz_dong@126.com.
Beijing Anzhen Hospital · CNCapital Medical University · CNAviation General Hospital · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal coronary revascularization strategy for patients with unprotected left main coronary artery (ULMCA) disease and left ventricular systolic dysfunction (LVSD) remains uncertain. The purpose of this study was to evaluate the clinical outcomes after percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) versus coronary artery bypass grafting (CABG) in patients with ULMCA disease with or without LVSD.

methodsA total of 984 patients with ULMCA disease who received a DES (n = 511) or underwent CABG (n = 473) were included in this study. We retrospectively analyzed the clinical parameters and outcomes of ULMCA disease patients with different left ventricular ejection fraction levels.

resultsThere were no significant differences in major adverse cardiac and cerebral events, all-cause death, cardiac death, myocardial infarction, or stroke between the CABG and DES groups with or without LVSD. The rate of target vessel revascularization was significantly higher with DES compared with CABG in patients without LVSD; however, the difference was not significant between the mild LVSD and severe LVSD groups.

conclusionFor patients with ULMCA disease and LVSD, there was no significant difference between DES and CABG in terms of efficacy and safety. Treatment with DES was an acceptable alternative to CABG.

Indexed as

Coronary Artery DiseaseDrug-Eluting StentsPercutaneous Coronary InterventionHumansRetrospective StudiesStroke VolumeTreatment OutcomeVentricular Function, LeftCoronary artery bypass graftingDrug-eluting stentMyocardial infarctionPercutaneous coronary interventionStroke

Identifiers

PMID32435839
OpenAlexW4242474188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.